Bacteria are growing increasingly antibiotic-resistant, but new research reveals how certain enzymes could be exploited to develop new classes of drugs to fight bacterial infections.
The Bronfenbrenner Center for Translational Research is launching a new project – the Community Neuroscience Initiative, or CNI – that will build connections between neuroscience, the social sciences and communities.
The environment surrounding the cells of a lymphoma tumor has a strong influence on the progression of these blood-cell cancers and their responses to therapies, according to a new study by Weill Cornell Medicine investigators.
Common fungi, often present in the gut, teach the immune system how to respond to their more dangerous relatives, according to new research from scientists at Weill Cornell Medicine.
Researchers led by Hening Lin have found a new way to potentially treat inflammatory bowel disease, as well as other autoimmune disorders, by targeting a mechanism that regulates the signaling pathway that enables inflammation to occur.
Cases of symptomatic COVID-19 were extremely low among children and staff at a network of North Carolina YMCA day camps that took precautions like masking and physical distancing, researchers have found.
Cornell researchers developed an imaging tool to create intricate spatial maps of the locations and identities of hundreds of different microbial species, such as those that make up the gut microbiome.
More than 70 faculty from Weill Cornell Medicine, Cornell Engineering and Cornell Tech assembled Oct. 1 at the Statler Ballroom — and more joined remotely — to kick off the Cornell Engineering Innovations in Medicine initiative.
A Cornell-led collaboration has developed a noninvasive blood test that uses cell-free DNA to gauge the damage that COVID-19 inflicts on cells, tissues and organs, and could help aid in the development of new therapies.